Petros Pharmaceuticals, Inc. Accrued Bonuses, Current
Petros Pharmaceuticals, Inc. (PTPI) had Accrued Bonuses, Current of $200.54 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Bonuses, Current $200.54K.
- 2026-03-31: Accrued Bonuses, Current $130.43K.
- 2025-09-30: Accrued Bonuses, Current $360.83K.
- 2025-06-30: Accrued Bonuses, Current $230.40K.
| Period end | Accrued Bonuses, Current |
|---|---|
| 2026-06-30 | $200.54K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $130.43K 10-Q · filed 2026-05-13 |
| 2025-09-30 | $360.83K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $230.40K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $112.15K 10-Q · filed 2025-05-15 |
| 2024-09-30 | $501.99K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $964.42K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $831.30K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $665.18K 10-K · filed 2025-03-31 |
| 2023-09-30 | $421.52K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $711.05K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $572.56K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $427.50K 10-K · filed 2024-04-01 |
| 2022-09-30 | $532.80K 10-Q/A · filed 2022-11-15 |
| 2021-12-31 | $527.56K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |